Medical Oncology投稿须知

期刊简介

《Medical Oncology》是由Springer US出版社于1984年创办的英文国际期刊（ISSN: 1357-0560，E-ISSN: 1559-131X），该期刊长期致力于肿瘤学领域的创新研究，主要研究方向为医学-肿瘤学。作为SCIE收录期刊（JCR分区 Q2，中科院 4区），本刊采用OA未开放获取模式（OA占比0.1891...%），以发表肿瘤学领域等方向的原创性研究为核心（研究类文章占比67.80%%）。凭借严格的同行评审与高效编辑流程，期刊年载文量精选控制在323篇，确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库，为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Medical Oncology审稿周期约为约1.4月。该刊近年未被列入国际预警名单，年发文量约323篇，录用竞争适中，主题需确保紧密契合医学前沿。投稿策略提示：避开学术会议旺季投稿以缩短周期，语言建议专业润色提升可读性。

医学大类学科
English 出版语言
否是否预警
SCIE 期刊收录
323 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊	综述期刊	大类学科	小类学科
否	否	医学 4区	ONCOLOGY 肿瘤学 4区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊	综述期刊	大类学科	小类学科
否	否	医学 4区	ONCOLOGY 肿瘤学 4区

JCR分区

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：ONCOLOGY	SCIE	Q2	157 / 322	51.4%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：ONCOLOGY	SCIE	Q3	169 / 322	47.67%

CiteScore

SJR

SNIP

CiteScore 排名

CiteScore：4.2

SJR：0.763

SNIP：0.623

学科类别	分区	排名	百分位
大类：Medicine 小类：Hematology	Q2	63 / 137	54%
大类：Medicine 小类：Oncology	Q2	194 / 404	52%
大类：Medicine 小类：Cancer Research	Q3	145 / 230	37%

期刊发文

ErbB2-upregulated HK1 and HK2 promote breast cancer cell proliferation, migration and invasion
Author: Ma, Xuejiao; Chen, Jingruo; Huang, Bohan; Fu, Shiqi; Qu, Shuai; Yu, Rong; Zhao, Yuhua

Journal: MEDICAL ONCOLOGY. 2023; Vol. 40, Issue 5, pp. -. DOI: 10.1007/s12032-023-02008-7
Classification of triple-negative breast cancer based on pathway enrichment levels
Author: Liu, Qian; Wang, Xiaosheng

Journal: MEDICAL ONCOLOGY. 2023; Vol. 40, Issue 6, pp. -. DOI: 10.1007/s12032-023-02021-w
P4HA3 promotes clear cell renal cell carcinoma progression via the PI3K/AKT/GSK3 beta pathway
Author: Zhang, Zhechuan; Zhang, Yuanfeng; Zhang, Ronggui

Journal: MEDICAL ONCOLOGY. 2023; Vol. 40, Issue 2, pp. -. DOI: 10.1007/s12032-022-01926-2
Downregulation of CEMIP enhances radiosensitivity by promoting DNA damage and apoptosis in colorectal cancer
Author: Weng, Jiawen; Zhang, Yuqin; Liang, Weijie; Xie, Yuwen; Wang, Kai; Xu, Qian; Ding, Yi; Li, Yiyi

Journal: MEDICAL ONCOLOGY. 2023; Vol. 40, Issue 2, pp. -. DOI: 10.1007/s12032-022-01940-4
Iodine-125 brachytherapy suppresses tumor growth and alters bone metabolism in a H1299 xenograft mouse model
Author: Bai, Jiangtao; Yu, Qiquan; Wang, Yuyang; Xu, Linshan; Wang, Jianping; Zhai, Jianglong; Bao, Qi; Guo, Wentao; Wu, Chunxiao; Zhang, Kun; Shou, Weizhen; Zhu, Guoying

Journal: MEDICAL ONCOLOGY. 2023; Vol. 40, Issue 2, pp. -. DOI: 10.1007/s12032-022-01937-z
A phase II study of chidamide, cytarabine, aclarubicin, granulocyte colony-stimulating factor, and donor lymphocyte infusion for relapsed acute myeloid leukemia and myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation
Author: Wei, Yan; Wang, Lijun; Zhu, Chengying; Li, Honghua; Bo, Jian; Zhang, Ran; Lu, Ning; Wu, Yongli; Gao, Xiaoning; Dou, Liping; Liu, Daihong; Gao, Chunji

Journal: MEDICAL ONCOLOGY. 2023; Vol. 40, Issue 2, pp. -. DOI: 10.1007/s12032-022-01911-9
SRC-3/TRAF4 facilitates ovarian cancer development by activating the PI3K/AKT signaling pathway
Author: Wang, Ying; Luo, Xia; Wu, Nayiyuan; Liao, Qianjin; Wang, Jing

Journal: MEDICAL ONCOLOGY. 2023; Vol. 40, Issue 2, pp. -. DOI: 10.1007/s12032-022-01944-0
Important oncogenic and immunogenic roles of SPP1 and CSF1 in hepatocellular carcinoma
Author: Xiang, Tianxin; Cheng, Na; Huang, Bo; Zhang, Xujun; Zeng, Ping

Journal: MEDICAL ONCOLOGY. 2023; Vol. 40, Issue 6, pp. -. DOI: 10.1007/s12032-023-02024-7

Medical Oncology

医学肿瘤学

期刊简介

投稿提示

中科院分区

JCR分区

CiteScore

期刊发文

相关期刊

怎样选择期刊

投稿相关问题

投稿后咨询